Standard Biotools Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Boston, MA
LAB chart
What traders are saying about $LAB
Latest postsStandard Biotools Inc. news
- ‘Resist the Temptation,’ Says Investor About Rocket Lab Stock
TipRanks ·
- Down Nearly 65% From Its 52-Week High, Has Rocket Lab Stock Become a Bargain Buy?
The Motley Fool ·
- Cantor Fitzgerald reiterates Rocket Lab stock rating after launch By Investing.com
Investing.com Australia ·
- Rocket Lab stock gains almost 4% after reporting 137% increase in order backlog and successful satellite launches
Traders Union ·
- Rocket Lab stock drops 25% amid Neutron rocket delay but analysts see nearly 150% upside potential.
Pluang ·
- Rocket Lab stock drops 30% despite 137% backlog growth and 100% upside potential amid Neutron launch delay.
Pluang ·
- Zai Lab Stock Gets A Phase 3 Push After Positive Lung Cancer Trial Data
Simply Wall Street ·
- Rocket Lab schedules November 9 results. Rocket Lab stock sits at USD 31.50 billion value
ad-hoc-news.de ·
- Standard BioTools Inc. Estimates – NASDAQ:LAB
TradingView ·
- Why is Zai Lab stock surging today? By Investing.com
Investing.com South Africa ·
- What's Going On With Rocket Lab Stock Friday?
TradingView ·
- ‘Can’t See the Forest for the Trees,’ Says Investor About Rocket Lab Stock
TipRanks ·
Standard Biotools Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $85.3M | $91.0M | $106.3M | $97.9M |
| Net income | -$74.9M | -$138.9M | -$74.7M | -$190.1M |
| Diluted EPS | $-0.20 | $-0.52 | $-0.94 | $-2.43 |
| Total assets (year end) | $567.8M | $612.3M | $323.1M | $390.3M |
| Cash and equivalents (year end) | $120.9M | $166.7M | $51.7M | $81.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Standard Biotools Inc.
- Ticker
- LAB (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1162194
- Former names
- FLUIDIGM CORP
Frequently asked questions
What exchange is Standard Biotools Inc. listed on?
Standard Biotools Inc. trades on the Nasdaq under the ticker symbol LAB.
What industry is Standard Biotools Inc. in?
Standard Biotools Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Standard Biotools Inc. headquartered?
Standard Biotools Inc.'s business address on file with the SEC is in Boston, MA.
When does Standard Biotools Inc.'s fiscal year end?
Standard Biotools Inc.'s fiscal year ends on December 31.
How much revenue did Standard Biotools Inc. report?
Standard Biotools Inc. reported $85.3M in revenue for calendar year 2025, according to its SEC filings.